Société Générale : Short-term turn-around to the downside ahead
Entry price | Target | Stop-loss | Potential |
---|
€28.37 |
€26.5 |
€29.25 |
+6.59% |
---|
The chart of shares in Société Générale suggests a correction over the short term. The timing to benefit from a likely reversal appears good.
Strengths● The company returns high margins, thereby supporting business profitability.
● Historically, the company has been releasing figures that are above expectations.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● This company will be of major interest to investors in search of a high dividend stock.
● For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 29.02.
● The stock is close to a major daily resistance at EUR 28.69, which should be gotten rid of so as to gain new appreciation potential.
● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● For the past year, analysts have significantly revised downwards their profit estimates.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.